ES2189323T3 - Procedimiento para la preparacion de 3-amino-2-oxo-pirrolidinas, productos intermedios y su utilizacion. - Google Patents

Procedimiento para la preparacion de 3-amino-2-oxo-pirrolidinas, productos intermedios y su utilizacion.

Info

Publication number
ES2189323T3
ES2189323T3 ES99116580T ES99116580T ES2189323T3 ES 2189323 T3 ES2189323 T3 ES 2189323T3 ES 99116580 T ES99116580 T ES 99116580T ES 99116580 T ES99116580 T ES 99116580T ES 2189323 T3 ES2189323 T3 ES 2189323T3
Authority
ES
Spain
Prior art keywords
halo
alkyl
substituted
optionally
alkoxyalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99116580T
Other languages
English (en)
Inventor
Karlheinz Drauz
Ingo Klement
Gunter Knaup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa GmbH filed Critical Degussa GmbH
Application granted granted Critical
Publication of ES2189323T3 publication Critical patent/ES2189323T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/12Sulfonium compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

La producción de derivados de la 3-amino-2-pirrolidinona, útiles como productos intermedios para la obtención de compuestos biológicamente activos, comprende la ciclación de un nuevo derivado de la metionina S-sustituida. Los derivados de la 3-amino-2-pirrolidinona (I) y sus sales se producen mediante la ciclación de un derivado de la metionina S-sustituido (II). Los derivados de la metionina S-sustituida (II) son nuevos. La producción de los derivados de la 3-amino-2-pirrolidinona (I) y de sus sales comprende la ciclación de un derivado de la metionina S-sustituida (II): R1 = H, alquilo, alquenilo, alcoxialquilo o acilo opcionalmente sustituidos con halo o grupos que contengan N, O, P o S; cicloalquilo opcionalmente insaturado, opcionalmente sustituido con alquilo, alquenilo, acilo, alcóxido, alcoxialquilo, halo o grupos que contengan N, O, P o S y que contengan opcionalmente heteroátomos en el anillo; arilo, aralquilo, heteroarilo o heteroaralquilo opcionalmente sustituido en el anillo con alquilo, alquenilo, alquinilo, acilo, alcóxido, alcoxialquilo, halo, CN, CONH2 o grupos que contengan N, O, P o S; o un aminoácido N- enlazado o un grupo peptídico; R2 = H, alquilo, alquenilo, alquinilo o alcoxialquilo opcionalmente sustituido con halo o grupos que contengan N, O, P o S; cicloalquilo opcionalmente insaturado, opcionalmente sustituido con alquilo, alquenilo, acilo, alcóxido, alcoxialquilo, halo o grupos que contengan N, O, P o S y/o que opcionalmente contengan heteroátomos en el anillo; arilo, aralquilo, heteroarilo o heteroaralquilo opcionalmente sustituido en el anillo con alquilo, alquenilo, alquinilo, acilo, alcóxido, alcoxialquilo, halo o grupos que contengan N, O, P o S; R3 = H; acilo, un aminoácido C- enlazado o un grupo peptídico; o un grupo de protección peptídico; e Y = alquileno opcionalmente sustituido con alquilo, halo, OH o fenilo; o aralquilo opcionalmente sustituido con alquilo, halo u OH. Las definiciones completas se dan en el campo DEFINICIONES (Definiciones Completas). También se incluyen reivindicaciones independientes para lo siguiente: 1) derivados de la metionina S-sustituidos de la fórmula (II) y sus sales de adición y 2) la preparación de compuestos de la fórmula (II).
ES99116580T 1998-09-11 1999-08-25 Procedimiento para la preparacion de 3-amino-2-oxo-pirrolidinas, productos intermedios y su utilizacion. Expired - Lifetime ES2189323T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19841895A DE19841895A1 (de) 1998-09-11 1998-09-11 Neues Verfahren zur Herstellung von 3-Amino-2-oxo-pyrrolidinen, neue Zwischenprodukte und deren Verwendung

Publications (1)

Publication Number Publication Date
ES2189323T3 true ES2189323T3 (es) 2003-07-01

Family

ID=7880819

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99116580T Expired - Lifetime ES2189323T3 (es) 1998-09-11 1999-08-25 Procedimiento para la preparacion de 3-amino-2-oxo-pirrolidinas, productos intermedios y su utilizacion.

Country Status (7)

Country Link
US (1) US6156908A (es)
EP (1) EP0985665B1 (es)
JP (1) JP2000086626A (es)
AT (1) ATE229504T1 (es)
DE (2) DE19841895A1 (es)
DK (1) DK0985665T3 (es)
ES (1) ES2189323T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8583001A1 (es) 2002-09-20 2004-04-23 Hoffmann La Roche Derivados de 4-pirrolidino-fenil-bencil eter como inhibidores de mao-b
WO2005007641A1 (en) * 2003-07-03 2005-01-27 Euro-Celtique S.A. 2-pyridine alkyne derivatives useful for treating pain
CA2543287A1 (en) 2003-10-23 2005-05-06 F.Hoffmann-La Roche Ag Benzazepine derivatives as mao-b inhibitors
CA2555961A1 (en) * 2004-02-23 2005-09-09 Trustees Of Tufts College Lactams as conformationally constrained peptidomimetic inhibitors
GB0518235D0 (en) * 2005-09-07 2005-10-19 Angeletti P Ist Richerche Bio Therapeutic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377515A (en) * 1979-10-01 1983-03-22 Merck & Co., Inc. Long lasting agonists and antagonists of LH-RH
US5721366A (en) * 1993-03-31 1998-02-24 G. D. Searle & Co Platelet aggregation inhibitors
US5610296A (en) * 1994-12-05 1997-03-11 G. D. Searle & Co. Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs

Also Published As

Publication number Publication date
DE19841895A1 (de) 2000-03-23
JP2000086626A (ja) 2000-03-28
EP0985665A1 (de) 2000-03-15
ATE229504T1 (de) 2002-12-15
US6156908A (en) 2000-12-05
DK0985665T3 (da) 2003-03-17
EP0985665B1 (de) 2002-12-11
DE59903722D1 (de) 2003-01-23

Similar Documents

Publication Publication Date Title
NO179638C (no) Analogifremgangsmåte for fremstilling av tiazolderivater
ES2156588T3 (es) Derivados de piperazina como antagonistas de taquiquinina.
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
MX9306831A (es) Nuevos compuestos heterociclicos.
FI950309A0 (fi) Proliiniamidijohdannaisia
DK0649418T3 (da) 7-(2-aminoethyl)benzothiazolon
BR1101136A (pt) Derivado da pristinamicina iib, (dietilamino-2 metil-1 etil) sulfinil-26 pristinamicina iib, (dietilamino-2 propil) sulfonil-26 pristinamicina iib, (diisopropilamino-2 etil) sulfonil-26 pristinamicina iib, processo de preparação de novo derivado da pristinamicina iib e composição farmacêutica
ES2189323T3 (es) Procedimiento para la preparacion de 3-amino-2-oxo-pirrolidinas, productos intermedios y su utilizacion.
DE69006452T2 (de) Derivate und Analoge von Pyrimidon zur Behandlung von Asthma und bestimmte Hautkrankheiten.
DE60016384D1 (de) Chondrogonese promotoren und indolin-2-on derivate
AU703092B2 (en) Benzene derivatives
DE69702955D1 (de) Bis-Imide Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitung
RO93389A (ro) Procedeu pentru prepararea unor derivati de 4-fluortiolcarbanilida
EP0826663A3 (en) Alkynylamino acid derivatives and their use as pharmaceutical compounds